CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner

Clara Quijano-Rubio, Manuela Silginer, Michael Weller

Open source

DOI
10.1038/s41420-022-01133-y
Published
2022-07-29
Container
Cell Death Discovery
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41420-022-01133-y,
  title = {CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner},
  author = {Clara Quijano-Rubio and Manuela Silginer and Michael Weller},
  year = {2022},
  journal = {Cell Death Discovery},
  doi = {10.1038/s41420-022-01133-y},
  url = {https://doi.org/10.1038/s41420-022-01133-y}
}

RIS

TY  - JOUR
TI  - CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner
AU  - Clara Quijano-Rubio
AU  - Manuela Silginer
AU  - Michael Weller
PY  - 2022
JO  - Cell Death Discovery
DO  - 10.1038/s41420-022-01133-y
UR  - https://doi.org/10.1038/s41420-022-01133-y
ER  - 

APA

Quijano-Rubio, C., Silginer, M., & Weller, M. (2022). CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner. Cell Death Discovery. https://doi.org/10.1038/s41420-022-01133-y

Source records